• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

EIF2B3 Antibody – Mouse Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS830159

MBS830159 is an antibody targeting EIF2B3. Also known as EIF2B3 antibody. Host: Mouse. Mouse monoclonal EIF2B3 antibody More details

$1615 / 0.1 mL +2 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
EIF2B3, Monoclonal Antibody
Full Product Name
EIF2B3 antibody
Product Gene Name
Product Synonym Names
Monoclonal EIF2B3; Anti-EIF2B3; Eukaryotic translation initiation factor 2B subunit 3 gamma; EIF-2B; EIF2Bgamma; Translation initiation factor eIF-2B subunit gamma; EIF2B3; EIFB3 2; EIFB3-2
Clonality
Monoclonal
Isotype
IgG1
Clone Number
3H3
Host
Mouse
Form/Format
Supplied in PBS buffer, pH 7.3, containing 1% BSA, 50% glycerol and 0.02% sodium azide.
Purity/Purification
EIF2B3 antibody was purified by affinity chromatography.
Concentration
500 ug-1 mg/ml (lot specific)
Preparation and Storage
Store at 4 degree C for short term storage. Aliquot and store at -20 degree C for long term storage. Avoid repeated freeze/thaw cycles.
Molecular Weight
44,803 Da
OMIM
603896
3D Structure
ModBase 3D Structure for Q9NR50
Cross-Reactivity
Human
Immunogen
EIF2B3 antibody was raised in mouse using a full length recombinant protein of human EIF2B3 (NP_065098) produced in HEK293T cells, as the immunogen.

Product Categories/Family for anti-EIF2B3 antibody

Applications Tested/Suitable for anti-EIF2B3 antibody
Immunohistochemistry (IHC), Western Blot (WB)
Application Notes for anti-EIF2B3 antibody
IHC: 1:150
WB: 1:2000

Western Blot (WB) of anti-EIF2B3 antibody

Western Blot analysis of HEK293T cell lysates (5 ug) transfected with either recombinant EIF2B3 protein (Right) or empty vector (Left) detected with EIF2B3 antibody
Mouse Anti-EIF2B3 Monoclonal Antibody – Cat# MBS830159

Other Notes

Small volumes of anti-EIF2B3 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for EIF2B3. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
translation initiation factor eIF-2B subunit gamma isoform 1
NCBI Official Synonym Full Names
eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa
NCBI Official Symbol
EIF2B3
NCBI Official Synonym Symbols
EIF-2B; EIF2Bgamma
UniProt Protein Name
Translation initiation factor eIF-2B subunit gamma
UniProt Synonym Protein Names
eIF-2B GDP-GTP exchange factor subunit gamma
UniProt Gene Name
EIF2B3
UniProt Entry Name
EI2BG_HUMAN
NCBI Protein Information
translation initiation factor eIF-2B subunit gamma

NCBI Summary for EIF2B3

The protein encoded by this gene is one of the subunits of initiation factor eIF2B, which catalyzes the exchange of eukaryotic initiation factor 2-bound GDP for GTP. It has also been found to function as a cofactor of hepatitis C virus internal ribosome entry site-mediated translation. Mutations in this gene have been associated with leukodystrophy with vanishing white matter. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Show more

UniProt Comments for EIF2B3

eIF2B-gamma: Catalyzes the exchange of eukaryotic initiation factor 2-bound GDP for GTP. Defects in EIF2B3 are a cause of leukodystrophy with vanishing white matter (VWM). VWM is a leukodystrophy that occurs mainly in children. Neurological signs include progressive cerebellar ataxia, spasticity, inconstant optic atrophy and relatively preserved mental abilities. The disease is chronic-progressive with, in most individuals, additional episodes of rapid deterioration following febrile infections or minor head trauma. While childhood onset is the most common form of the disorder, some severe forms are apparent at birth. A severe, early-onset form seen among the Cree and Chippewayan populations of Quebec and Manitoba is called Cree leukoencephalopathy. Milder forms may not become evident until adolescence or adulthood. Some females with milder forms of the disease who survive to adolescence exhibit ovarian dysfunction. This variant of the disorder is called ovarioleukodystrophy. Belongs to the eIF-2B gamma/epsilon subunits family. 3 isoforms of the human protein are produced by alternative splicing.

Protein type: Translation initiation; Translation

Chromosomal Location of Human Ortholog: 1p34.1

Cellular Component: eukaryotic translation initiation factor 2B complex; cytoplasm; cytosol

Molecular Function: protein binding; translation factor activity, nucleic acid binding; guanyl-nucleotide exchange factor activity; translation initiation factor activity; nucleotidyltransferase activity

Biological Process: response to peptide hormone stimulus; cellular protein metabolic process; translation; response to heat; translational initiation; response to glucose stimulus; negative regulation of translation initiation in response to stress; cellular response to stimulus; gene expression; oligodendrocyte development; positive regulation of GTPase activity

Disease: Leukoencephalopathy With Vanishing White Matter
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Organs/Tissues associated with anti-EIF2B3 antibody

Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000